Page last updated: 2024-10-28

haloperidol and Hemosiderosis

haloperidol has been researched along with Hemosiderosis in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Hemosiderosis: Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, WG1
Raskind, MA1
Gordon, T1
Shaw, CM1

Other Studies

1 other study available for haloperidol and Hemosiderosis

ArticleYear
Iron pigment in the brain of a man with tardive dyskinesia.
    The American journal of psychiatry, 1985, Volume: 142, Issue:3

    Topics: Basal Ganglia; Bipolar Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gliosis; Halop

1985